The purpose of the study was to formulate a cisapride suspension that
would be stable under usual storage conditions for 3 weeks. Cisapride
is a new prokinetic agent that is available as a coated tablet; occasi
onally, however, patients require a liquid preparation of cisapride. C
isapride was formulated with propylene glycol to enhance its solubilit
y. The suspension was buffered with sodium bicarbonate to produce a pH
between 6.5 and 7.5. The formulation provided a cisapride suspension
that was stable at room temperature for 3 weeks.